SG11201601477VA - Pharmaceutical composition - Google Patents
Pharmaceutical compositionInfo
- Publication number
- SG11201601477VA SG11201601477VA SG11201601477VA SG11201601477VA SG11201601477VA SG 11201601477V A SG11201601477V A SG 11201601477VA SG 11201601477V A SG11201601477V A SG 11201601477VA SG 11201601477V A SG11201601477V A SG 11201601477VA SG 11201601477V A SG11201601477V A SG 11201601477VA
- Authority
- SG
- Singapore
- Prior art keywords
- pharmaceutical composition
- pharmaceutical
- composition
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN3124MU2013 IN2013MU03124A (enExample) | 2013-09-30 | 2014-09-29 | |
| PCT/IB2014/064922 WO2015044922A1 (en) | 2013-09-30 | 2014-09-29 | Pharmaceutical composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201601477VA true SG11201601477VA (en) | 2016-04-28 |
Family
ID=51903957
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201601477VA SG11201601477VA (en) | 2013-09-30 | 2014-09-29 | Pharmaceutical composition |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20160271226A1 (enExample) |
| EP (1) | EP3052114A1 (enExample) |
| JP (1) | JP2016531847A (enExample) |
| CN (1) | CN105579052A (enExample) |
| AU (1) | AU2014326181A1 (enExample) |
| BR (1) | BR112016006963A2 (enExample) |
| IN (1) | IN2013MU03124A (enExample) |
| RU (1) | RU2016107610A (enExample) |
| SG (1) | SG11201601477VA (enExample) |
| WO (1) | WO2015044922A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108712910A (zh) * | 2016-02-25 | 2018-10-26 | 沃克哈特有限公司 | 胰岛素和氨基酸的药物组合物 |
| CN106729639B (zh) * | 2017-01-10 | 2018-02-27 | 鲁南制药集团股份有限公司 | 一种甘精胰岛素注射液及其制备方法 |
| KR102757948B1 (ko) * | 2017-07-27 | 2025-01-23 | 아도시아 | 적어도 사람 인슐린 a21g 및 식사 작용 글루카곤 억제제를 포함하는 주사가능한 수용액 형태의 조성물 |
| CA3149925A1 (en) * | 2019-08-02 | 2021-02-11 | Case Western Reserve University | Premixed ultra-stable single-chain insulin analogue formulations |
| EP3915571A1 (en) * | 2020-05-29 | 2021-12-01 | Adocia | Pharmaceutical composition in the form of an injectable aqueous solution including at least a rapid acting insulin analog and a glucagon suppressor with prandial action |
| EP3915572A1 (en) * | 2020-05-29 | 2021-12-01 | Adocia | Pharmaceutical composition in the form of an injectable aqueous solution including at least a rapid acting insulin analog and a glucagon suppressor with prandial action |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3316363A1 (de) | 1983-05-05 | 1984-11-08 | Deutsche Babcock Anlagen Ag, 4200 Oberhausen | Walzenrost fuer muellverbrennungsanlagen |
| PH25772A (en) | 1985-08-30 | 1991-10-18 | Novo Industri As | Insulin analogues, process for their preparation |
| DK257988D0 (da) | 1988-05-11 | 1988-05-11 | Novo Industri As | Nye peptider |
| HUT56857A (en) | 1988-12-23 | 1991-10-28 | Novo Nordisk As | Human insulin analogues |
| IL93282A (en) | 1989-02-09 | 1995-08-31 | Lilly Co Eli | Insulin analogues |
| DK155690D0 (da) | 1990-06-28 | 1990-06-28 | Novo Nordisk As | Nye peptider |
| AU2003218635A1 (en) * | 2002-05-07 | 2003-11-11 | Novo Nordisk A/S | Soluble formulations comprising insulin aspart and insulin detemir |
| CN101237855A (zh) * | 2005-05-23 | 2008-08-06 | Sdg公司 | 将干扰素输送到哺乳动物的脂构建体 |
| DK3391876T3 (da) * | 2005-05-23 | 2021-06-14 | Sdg Inc | Lipidkonstrukt til afgivelse af insulin til et pattedyr |
| US8084420B2 (en) | 2005-09-29 | 2011-12-27 | Biodel Inc. | Rapid acting and long acting insulin combination formulations |
| US7713929B2 (en) * | 2006-04-12 | 2010-05-11 | Biodel Inc. | Rapid acting and long acting insulin combination formulations |
| WO2007041481A1 (en) | 2005-09-29 | 2007-04-12 | Biodel, Inc. | Rapid acting and prolonged acting insulin preparations |
| CN101454019A (zh) * | 2006-04-12 | 2009-06-10 | 百达尔公司 | 速效和长效胰岛素联合制剂 |
| CA2649109A1 (en) | 2006-04-12 | 2007-10-25 | Biodel, Inc. | Rapid acting and long acting insulin combination formulations |
| ES2558930T3 (es) | 2007-08-13 | 2016-02-09 | Novo Nordisk A/S | Análogos de la insulina de acción rápida |
| EP2178911A2 (en) | 2007-08-13 | 2010-04-28 | Novo Nordisk A/S | Rapid acting insulin analogues |
| WO2011094632A1 (en) | 2010-01-29 | 2011-08-04 | The Uab Research Foundation | Method for administration of insulin and pharmaceutical composition thereof |
| US20130331320A1 (en) * | 2010-12-14 | 2013-12-12 | Novo Nordisk A/S | Fast-acting insulin in combination with long-acting insulin |
| DK2741765T3 (en) | 2011-08-10 | 2016-06-13 | Adocia | Injectable solution of at least one type of basal insulin |
-
2014
- 2014-09-29 IN IN3124MU2013 patent/IN2013MU03124A/en unknown
- 2014-09-29 WO PCT/IB2014/064922 patent/WO2015044922A1/en not_active Ceased
- 2014-09-29 AU AU2014326181A patent/AU2014326181A1/en not_active Abandoned
- 2014-09-29 US US15/021,693 patent/US20160271226A1/en not_active Abandoned
- 2014-09-29 EP EP14799538.5A patent/EP3052114A1/en not_active Withdrawn
- 2014-09-29 BR BR112016006963A patent/BR112016006963A2/pt not_active Application Discontinuation
- 2014-09-29 SG SG11201601477VA patent/SG11201601477VA/en unknown
- 2014-09-29 JP JP2016515453A patent/JP2016531847A/ja active Pending
- 2014-09-29 RU RU2016107610A patent/RU2016107610A/ru unknown
- 2014-09-29 CN CN201480053586.6A patent/CN105579052A/zh not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| BR112016006963A2 (pt) | 2017-08-01 |
| US20160271226A1 (en) | 2016-09-22 |
| CN105579052A (zh) | 2016-05-11 |
| RU2016107610A (ru) | 2017-11-03 |
| EP3052114A1 (en) | 2016-08-10 |
| JP2016531847A (ja) | 2016-10-13 |
| IN2013MU03124A (enExample) | 2015-07-31 |
| WO2015044922A1 (en) | 2015-04-02 |
| AU2014326181A1 (en) | 2016-03-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL288961A (en) | Pharmaceutical preparations | |
| PL3030262T3 (pl) | Złożona kompozycja farmaceutyczna | |
| PL2943181T3 (pl) | Kompozycje farmaceutyczne | |
| GB201322602D0 (en) | Pharmaceutical compounds | |
| GB201306610D0 (en) | Pharmaceutical compounds | |
| ZA201408333B (en) | Pharmaceutical compositions | |
| PL3043778T3 (pl) | Kompozycje farmaceutyczne zawierające refametinib | |
| ZA201602047B (en) | Pharmaceutical compounds | |
| SG11201601477VA (en) | Pharmaceutical composition | |
| IL242704B (en) | Pharmacy preparation | |
| HUP1300496A2 (hu) | Stabil kombinációs gyógyszerkészítmény | |
| GB201312386D0 (en) | Pharmaceutical compounds | |
| IL244365A0 (en) | pharmaceutical preparation | |
| AP2015008890A0 (en) | Pharmaceutical compositions | |
| GB201304699D0 (en) | Pharmaceutical compositions | |
| GB201317166D0 (en) | Pharmaceutical compounds | |
| GB201304625D0 (en) | New pharmaceutical composition | |
| GB201321497D0 (en) | Pharmaceutical compositions | |
| GB201312851D0 (en) | Pharmaceutical compositions | |
| ZA201506465B (en) | Pharmaceutical preparation | |
| GB201316662D0 (en) | Pharmaceutical Combination | |
| GB201310496D0 (en) | Pharmaceutical combinations | |
| GB201301723D0 (en) | Pharmaceutical combinations | |
| GB201316791D0 (en) | Pharmaceutical Compounds | |
| GB201316780D0 (en) | Pharmaceutical compounds |